Transcode Therapeutics logo

Transcode Therapeutics Share Price Today

(NASDAQ: RNAZ)

Transcode Therapeutics share price is $1.83 & ₹159.15 as on 6 Mar 2025, 2.30 'hrs' IST

$1.83

-0.04

(-2.14%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Transcode Therapeutics share price in Dollar and Rupees. Guide to invest in Transcode Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Transcode Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Transcode Therapeutics share price movements

  • Today's Low: $1.75
    Today's High: $2.00

    Day's Volatility :12.5%

  • 52 Weeks Low: $1.75
    52 Weeks High: $66.33

    52 Weeks Volatility :97.36%

Transcode Therapeutics (RNAZ) Returns

PeriodTranscode Therapeutics IncIndex (Russel 2000)
3 Months
-78.51%
0.0%
6 Months
-79.39%
0.0%
1 Year
-91.9%
0.0%
3 Years
-100.0%
-11.6%

Transcode Therapeutics (RNAZ) Key Statistics

in dollars & INR

Previous Close
$1.87
Open
$1.88
Today's High
$2.0
Today's Low
$1.75
Market Capitalization
$1.3M
Today's Volume
$120.4K
52 Week High
$66.33
52 Week Low
$1.75
Revenue TTM
$0.0
EBITDA
$-14.6M
Earnings Per Share (EPS)
$5571.72
PE Ratio
0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-490.03%

How to invest in Transcode Therapeutics Stock (RNAZ) from India?

It is very easy for Indian residents to invest directly in Transcode Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Transcode Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Transcode Therapeutics or RNAZ on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Transcode Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Transcode Therapeutics shares which would translate to 0.475 fractional shares of Transcode Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Transcode Therapeutics, in just a few clicks!

Returns in Transcode Therapeutics (RNAZ) for Indian investors in Rupees

The Transcode Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Transcode Therapeutics investment value today

Current value as on today

₹12,885

Returns

₹87,115

(-87.12%)

Returns from Transcode Therapeutics Stock

₹92,078 (-92.08%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Transcode Therapeutics (RNAZ)

13.11%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Transcode Therapeutics Shares from India has grown by 13.11% over the past 30 days, indicating increased transactional activity.

-42%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Transcode Therapeutics Stock from India on INDmoney has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Transcode Therapeutics

  • UBS Group AG

    1.25%

  • Tower Research Capital LLC

    0.13%

  • Morgan Stanley - Brokerage Accounts

    0.04%

Analyst Recommendation on Transcode Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Transcode Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Transcode Therapeutics Stock (RNAZ)

What analysts predicted

Upside of 992.9%

Target:

$20.00

Current:

$1.83

Insights on Transcode Therapeutics Stock (Ticker Symbol: RNAZ)

  • Price Movement

    In the last 7 days, RNAZ stock has moved down by -44.2%
  • RNAZ vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 154.1%
  • RNAZ vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 147.7%

Transcode Therapeutics Technicals Summary

Sell

Neutral

Buy

Transcode Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Transcode Therapeutics (RNAZ) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Transcode Therapeutics Inc logo
-75.07%
-79.39%
-91.9%
-100.0%
-100.0%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Transcode Therapeutics Inc logo
0.0
0.0
NA
-4.76
-4.9
-1.29
NA
3.16
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Transcode Therapeutics Inc logo
Buy
$1.3M
-100.0%
0.0
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Transcode Therapeutics

TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer. The company's lead therapeutic candidate comprises TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in various cancers comprising breast, pancreatic, ovarian, colon cancer, glioblastomas, and others. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 and two indication agnostic programs; TTX-RIGA, an RNA- based agonist of the retinoic acid-inducible gene I targeting activation of innate immunity in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines that activate cytotoxic immune responses against tumor cells. TransCode Therapeutics, Inc. has strategic collaboration agreement with The University of Texas M. D. Anderson Cancer Center. The company was incorporated in 2016 and is based in Boston, Massachusetts.
Organization
Transcode Therapeutics
Employees
8
CEO
Mr. Thomas A. Fitzgerald M.B.A.
Industry
Miscellaneous

Management People of Transcode Therapeutics

NameTitle
Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D.
Executive Chairman of the Board
Mr. Thomas A. Fitzgerald M.B.A.
Interim CEO, CFO, President, VP of Administration & Director
Dr. Zdravka Medarova Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Anna Moore Ph.D.
Co-Founder, Scientific Advisor & Member of Scientific Advisory Board
Ms. Susan Duggan M.B.A., R.N.
Senior Vice President of Operations
Dr. Daniel R. Vlock M.D.
Chief Medical Officer

Important FAQs about investing in RNAZ Stock from India :

What is Transcode Therapeutics share price today?

Transcode Therapeutics share price today stands at $1.83, Open: $1.88 ; Previous Close: $1.87 ; High: $2.00 ; Low: $1.75 ; 52 Week High: $66.33 ; 52 Week Low: $1.75.

The stock opens at $1.88, after a previous close of $1.87. The stock reached a daily high of $2.00 and a low of $1.75, with a 52-week high of $66.33 and a 52-week low of $1.75.

Can Indians buy Transcode Therapeutics shares?

Yes, Indians can invest in the Transcode Therapeutics (RNAZ) from India.

With INDmoney, you can buy Transcode Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Transcode Therapeutics at zero transaction cost.

How can I buy Transcode Therapeutics shares from India?

It is very easy to buy Transcode Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Transcode Therapeutics (RNAZ) be purchased?

Yes, you can buy fractional shares of Transcode Therapeutics with INDmoney app.

What are the documents required to start investing in Transcode Therapeutics stocks?

To start investing in Transcode Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Transcode Therapeutics Stock (RNAZ)?

Today’s highest price of Transcode Therapeutics (RNAZ) is $2.00.

Today’s lowest price of Transcode Therapeutics (RNAZ) is $1.75.

What is today's market capitalisation of Transcode Therapeutics?

Today's market capitalisation of Transcode Therapeutics RNAZ is 1.3M

What is the 52 Week High and Low Range of Transcode Therapeutics Stock (RNAZ)?

  • 52 Week High

    $66.33

  • 52 Week Low

    $1.75

What are the historical returns of Transcode Therapeutics (RNAZ)?

  • 1 Month Returns

    -75.07%

  • 3 Months Returns

    -79.39%

  • 1 Year Returns

    -91.9%

  • 5 Years Returns

    -100%

Who is the Chief Executive Officer (CEO) of Transcode Therapeutics ?

Mr. Thomas A. Fitzgerald M.B.A. is the current Chief Executive Officer (CEO) of Transcode Therapeutics.